Medicxi Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 10
Professionals
  • Investments
  • 45
  • Portfolio
  • 24
  • Exits
  • 16
Exits

Medicxi General Information

Description

Founded in 2016, Medicxi is a venture capital firm headquartered in London, United Kingdom with regional offices in Geneva and Saint Helier. The firm prefers to invest in the healthcare, academia, biotech, and pharmaceutical sectors.

Contact Information

Website
www.medicxi.com
Formerly Known As
Index Ventures Life Sciences
Year Founded
2016
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 25 Great Pulteney Street
  • London W1F 9LT
  • England, United Kingdom
+44 020 0000 0000

Medicxi Investments (45)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Monopteros Therapeutics 22-Apr-2021 Early Stage VC 0000 Biotechnology Startup 00000 0000000
0000 00000000000 22-Mar-2021 00000 00000 0000 Drug Discovery Clinical Trials - General 00000000 0000000 00.0
00000000 000000000 29-Jan-2021 00000 00000 00000 Drug Discovery Clinical Trials - Phase 3 000000000 00 00000000 00.0
00000000 000000000 01-Dec-2020 00000 00000 000.00 Drug Discovery Generating Revenue 000000000 00 00000000 00.0
00000 000000000000 11-Nov-2020 00000 00000 000.00 Drug Discovery Clinical Trials - General 000000000 00 00000000 00.0
000000 07-Oct-2020 00000 00000 000.00 Discovery Tools (Healthcare) Clinical Trials - General 0000000 00000000
000000000 00000000 09-Jun-2020 00000 00000 000.00 Other Pharmaceuticals and Biotechnology Clinical Trials - Phase 2
0000000 0000000000 01-May-2020 00000 00000 000.00 Biotechnology Clinical Trials - Phase 1 00000000 0000000 00.0
Vaxcyte 26-Mar-2020 Later Stage VC 00000 Drug Discovery Startup 000000 000000 00.0
Alderaan Biotechnology 09-Jan-2020 Early Stage VC 000.00 Biotechnology Pre-Clinical Trials 0000è00 000000 00
You’re viewing 10 of 45 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medicxi Exits (16)

Company Name Exit Date Exit Type Exit Size
Morphogen-IX 23-Feb-2021 Merger/Acquisition
000000 16-Feb-2021 000000000000000000
000000 16-Feb-2021 000000000000000000
0000000000 000 16-Feb-2021 000000000000000000
0000000 0000000000 12-Feb-2021 0000000000: 000000
00000 00000000 000 23-Nov-2020 0000000000: 000000
000000000 00000000 07-Aug-2020 000 0000
0000000 12-Jun-2020 000 00000
SuperX 06-Apr-2020 Bankruptcy: Liquidation
Phathom Pharmaceuticals 25-Oct-2019 IPO 00000
You’re viewing 10 of 16 exits. Get the full list »

Medicxi Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Medicxi‘s full profile, request access.

Request a free trial

Medicxi Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Medicxi Team (26)

Name Title Deals Funds Boards Office
Thibaut De Smedt Ph.D Venture Partner London, United Kingdom
Trevor Baglin Ph.D Venture Partner, Investment Team London, United Kingdom
Francesco De Rubertis Ph.D Co-Founder & Partner 00 0 0 Geneva, Switzerland
Kevin Johnson Ph.D Co-Founder & Partner 00 0 0 London, United Kingdom
Michèle Ollier MD Co-Founder & Partner 00 0 0 Geneva, Switzerland
You’re viewing 5 of 26 team members. Get the full list »